Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease.

× No keyword cloud information.

15 in total

Review 1. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause!

Authors: S V Shrikhande; S G Barreto; S Singh; T E Udwadia; A K Agarwal
Journal: Eur J Surg Oncol Date: 2010-05-26 Impact factor: 4.424

2. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes.

Authors: John M Creasy; Debra A Goldman; Vikas Dudeja; Maeve A Lowery; Andrea Cercek; Vinod P Balachandran; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; Michael I D'Angelica; William R Jarnagin
Journal: J Am Coll Surg Date: 2017-02-13 Impact factor: 6.113

3. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Authors: Jae Yong Cho; Yong Han Paik; Yoon Soo Chang; Se Joon Lee; Dong-Ki Lee; Si Young Song; Jae Bock Chung; Mi-Suk Park; Jeong-Sik Yu; Dong-Sup Yoon
Journal: Cancer Date: 2005-12-15 Impact factor: 6.860

4. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors: J W Valle; I Borbath; S A Khan; F Huguet; T Gruenberger; D Arnold
Journal: Ann Oncol Date: 2016-09 Impact factor: 32.976

5. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

Authors: Jennifer J Knox; David Hedley; Amit Oza; Ron Feld; Lillian L Siu; Eric Chen; Mahsan Nematollahi; Gregory R Pond; Jessica Zhang; Malcolm J Moore
Journal: J Clin Oncol Date: 2005-04-01 Impact factor: 44.544

Review 6. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis.

Authors: Rui Yang; Bing Wang; Yong-jun Chen; Hong-bo Li; Jun-bo Hu; Sheng-quan Zou
Journal: Anticancer Drugs Date: 2013-09 Impact factor: 2.248

7. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy.

Authors: S Sheth; A Bedford; S Chopra
Journal: Am J Gastroenterol Date: 2000-06 Impact factor: 10.864

8. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications?

Authors: Hideki Nishio; Masato Nagino; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Yuji Nimura
Journal: J Hepatobiliary Pancreat Surg Date: 2007-07-30

9. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer.

Authors: Rachel P Riechelmann; Carol A Townsley; Sheray N Chin; Gregory R Pond; Jennifer J Knox
Journal: Cancer Date: 2007-09-15 Impact factor: 6.860

10. Role of radical surgery in patients with stage IV gallbladder cancer.

Authors: Mee Joo Kang; Youngpeck Song; Jin-Young Jang; In Woong Han; Sun-Whe Kim
Journal: HPB (Oxford) Date: 2012-08-20 Impact factor: 3.647

2 in total

1. Curative intent radical cholecystectomy followed by hyperthermic intraperitoneal chemotherapy in ruptured intraductal papillary neoplasm of gallbladder with invasive carcinoma.

Authors: Gyeonggyu Choi; Seokwon Jang; Munseok Choi; Seungyoon Yang; Chunggeun Lee; Chang Moo Kang
Journal: Ann Hepatobiliary Pancreat Surg Date: 2022-02-28

2. Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy.

Authors: Ziyi Yang; Ziyou Wu; Yichen Xiong; Shilei Liu; Chen Cai; Ziyu Shao; Yidi Zhu; Xiaoling Song; Wei Shen; Xuefeng Wang; Xiangsong Wu; Wei Gong
Journal: Front Oncol Date: 2022-08-16 Impact factor: 5.738

2 in total